Page 110 - Read Online
P. 110

Page 10 of 12                Jones et al. Microbiome Res Rep 2024;3:24  https://dx.doi.org/10.20517/mrr.2023.78

               Ethical approval and consent to participate
               Not applicable.


               Consent for publication
               Not applicable.


               Copyright
               © The Author(s) 2024.


               REFERENCES
               1.       Aragón IM, Herrera-Imbroda B, Queipo-Ortuño MI, et al. The urinary tract microbiome in health and disease. Eur Urol Focus
                   2018;4:128-38.  DOI
               2.       Newstead LL, Varjonen K, Nuttall T, Paterson GK. Staphylococcal-produced bacteriocins and antimicrobial peptides: their potential as
                   alternative treatments for Staphylococcus aureus infections. Antibiotics 2020;9:40.  DOI  PubMed  PMC
               3.       Valles-Colomer M, Manghi P, Cumbo F, et al. Neuroblastoma is associated with alterations in gut microbiome composition
                   subsequent to maternal microbial seeding. EBioMedicine 2024;99:104917.  DOI  PubMed  PMC
               4.       Xie J, Liu M, Deng X, et al. Gut microbiota reshapes cancer immunotherapy efficacy: mechanisms and therapeutic strategies. iMeta
                   2024;3:e156.  DOI
               5.       Zheng J, Gänzle MG, Lin XB, Ruan L, Sun M. Diversity and dynamics of bacteriocins from human microbiome. Environ Microbiol
                   2015;17:2133-43.  DOI  PubMed
               6.       Mousa WK, Athar B, Merwin NJ, Magarvey NA. Antibiotics and specialized metabolites from the human microbiota. Nat Prod Rep
                   2017;34:1302-31.  DOI  PubMed
               7.       Culligan EP, Sleator RD. Advances in the microbiome: applications to Clostridium difficile infection. J Clin Med 2016;5:83.  DOI
                   PubMed  PMC
               8.       O’Sullivan JN, Rea MC, O’Connor PM, Hill C, Ross RP. Human skin microbiota is a rich source of bacteriocin-producing
                   staphylococci that kill human pathogens. FEMS Microbiol Ecol 2019;95:fiy241.  DOI  PubMed  PMC
               9.       Wosinska L, Walsh CJ, O’Connor PM, et al. In vitro and in silico based approaches to identify potential novel bacteriocins from the
                   athlete gut microbiome of an elite athlete cohort. Microorganisms 2022;10:701.  DOI  PubMed  PMC
               10.      Angelopoulou A, Warda AK, O’Connor PM, et al. Diverse bacteriocins produced by strains from the human milk microbiota. Front
                   Microbiol 2020;11:788.  PubMed  PMC
               11.      King AM, Zhang Z, Glassey E, Siuti P, Clardy J, Voigt CA. Systematic mining of the human microbiome identifies antimicrobial
                   peptides with diverse activity spectra. Nat Microbiol 2023;8:2420-34.  DOI  PubMed
               12.      Jones J, Murphy CP, Sleator RD, Culligan EP. The urobiome, urinary tract infections, and the need for alternative therapeutics. Microb
                   Pathog 2021;161:105295.  DOI  PubMed
               13.      Brubaker L, Putonti C, Dong Q, Wolfe AJ. The human urobiome. Mamm Genome 2021;32:232-8.  DOI  PubMed
               14.      Acedo JZ, Chiorean S, Vederas JC, van Belkum MJ. The expanding structural variety among bacteriocins from Gram-positive
                   bacteria. FEMS Microbiol Rev 2018;42:805-28.  DOI  PubMed
               15.      Chikindas ML, Weeks R, Drider D, Chistyakov VA, Dicks LM. Functions and emerging applications of bacteriocins. Curr Opin
                   Biotechnol 2018;49:23-8.  DOI  PubMed  PMC
               16.      Riley MA, Wertz JE. Bacteriocins: evolution, ecology, and application. Annu Rev Microbiol 2002;56:117-37.  DOI  PubMed
               17.      Héchard Y, Sahl HG. Mode of action of modified and unmodified bacteriocins from Gram-positive bacteria. Biochimie 2002;84:545-
                   57.  DOI  PubMed
               18.      Heilbronner S, Krismer B, Brötz-Oesterhelt H, Peschel A. The microbiome-shaping roles of bacteriocins. Nat Rev Microbiol
                   2021;19:726-39.  DOI  PubMed
               19.      Chavan MA, Riley MA. Molecular evolution of bacteriocins in gram-negative bacteria. In: Riley MA, Chavan MA, editors.
                   Bacteriocins. Berlin: Springer Berlin Heidelberg; 2007. pp. 19-43.  DOI
               20.      Ghodhbane H, Elaidi S, Sabatier JM, Achour S, Benhmida J, Regaya I. Bacteriocins active against multi-resistant gram negative
                   bacteria implicated in nosocomial infections. Infect Disord Drug Targets 2015;15:2-12.  DOI  PubMed
               21.      Jack RW, Tagg JR, Ray B. Bacteriocins of gram-positive bacteria. Microbiol Rev 1995;59:171-200.  DOI  PubMed  PMC
               22.      Klaenhammer TR. Bacteriocins of lactic acid bacteria. Biochimie 1988;70:337-49.  DOI  PubMed
               23.      Cotter PD, Ross RP, Hill C. Bacteriocins - a viable alternative to antibiotics? Nat Rev Microbiol 2013;11:95-105.  DOI  PubMed
               24.      Benítez-Chao DF, León-Buitimea A, Lerma-Escalera JA, Morones-Ramírez JR. Bacteriocins: an overview of antimicrobial, toxicity,
                   and biosafety assessment by in vivo models. Front Microbiol 2021;12:630695.  DOI  PubMed  PMC
               25.      Egan K, Field D, Ross RP, Cotter PD, Hill C. In silico prediction and exploration of potential bacteriocin gene clusters within the
                   bacterial genus Geobacillus. Front Microbiol 2018;9:2116.  DOI  PubMed  PMC
               26.      van Heel AJ, de Jong A, Song C, Viel JH, Kok J, Kuipers OP. BAGEL4: a user-friendly web server to thoroughly mine RiPPs and
                   bacteriocins. Nucleic Acids Res 2018;46:W278-81.  DOI  PubMed  PMC
   105   106   107   108   109   110   111   112   113   114   115